
|Articles|October 1, 2002
Supplements and Featured Publications
- Cardiorenal Differences Among NSAIDs and Coxibs: Real-World Experience
- Volume 8
- Issue 15 Suppl
Cyclooxygenase-2-Specific Inhibitors and Cardiorenal Function: A Randomized, Controlled Trial of Celecoxib and Rofecoxib in Older Hypertensive Osteoarthritis Patients
Advertisement
Articles in this issue
about 23 years ago
Participating Facultyabout 23 years ago
Cardiorenal Differences Among NSAIDs and Coxibs: Real-World ExperienceNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
4
Value-Based Care Interventions and Management of CKD Progression
5